Publicaciones en colaboración con investigadores/as de Centro de Investigacion Biomedica en Red de Enfermedades Respiratorias (10)

2023

  1. Publisher Correction: Early corticosteroids are associated with lower mortality in critically ill patients with COVID‑19: a cohort study (Critical Care, (2021), 25, 1, (2), 10.1186/s13054-020-03422-3)

    Critical Care

2022

  1. Therapeutic versus Prophylactic Bemiparin in Hospitalized Patients with Nonsevere COVID-19 Pneumonia (BEMICOP Study): An Open-Label, Multicenter, Randomized, Controlled Trial

    Thrombosis and Haemostasis, Vol. 122, Núm. 2, pp. 295-299

2021

  1. Correction to: Clinical features, ventilatory management, and outcome of ARDS caused by COVID-19 are similar to other causes of ARDS (Intensive Care Medicine, (2020), 46, 12, (2200-2211), 10.1007/s00134-020-06192-2)

    Intensive Care Medicine

  2. Early corticosteroids are associated with lower mortality in critically ill patients with COVID-19: a cohort study

    Critical Care, Vol. 25, Núm. 1

  3. High-flow nasal oxygen in patients with COVID-19-associated acute respiratory failure

    Critical Care, Vol. 25, Núm. 1

  4. Predictors of failure with high-flow nasal oxygen therapy in COVID-19 patients with acute respiratory failure: a multicenter observational study

    Journal of Intensive Care, Vol. 9, Núm. 1

2020

  1. Awake prone positioning does not reduce the risk of intubation in COVID-19 treated with high-flow nasal oxygen therapy: A multicenter, adjusted cohort study

    Critical Care, Vol. 24, Núm. 1

  2. Clinical features, ventilatory management, and outcome of ARDS caused by COVID-19 are similar to other causes of ARDS

    Intensive Care Medicine, Vol. 46, Núm. 12, pp. 2200-2211

  3. Patient characteristics, clinical course and factors associated to ICU mortality in critically ill patients infected with SARS-CoV-2 in Spain: A prospective, cohort, multicentre study

    Revista Espanola de Anestesiologia y Reanimacion, Vol. 67, Núm. 8, pp. 425-437

2017

  1. Omalizumab efficacy in cases of chronic spontaneous urticaria is not explained by the inhibition of sera activity in effector cells

    Scientific Reports, Vol. 7, Núm. 1